For: | Li GQ, Li H, Zhang HF. Mad2 and p53 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol 2003; 9(9): 1972-1975 [PMID: 12970887 DOI: 10.3748/wjg.v9.i9.1972] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i9/1972.htm |
Number | Citing Articles |
1 |
Alejandro López-Saavedra, Luis A. Herrera. The role of alternative mRNA splicing in chromosome instability. Mutation Research/Reviews in Mutation Research 2010; 705(3): 246 doi: 10.1016/j.mrrev.2010.09.002
|
2 |
Ulrike Gerlach, Gian Kayser, Axel Walch, Ulrich Hopt, Jürgen Schulte‐Mönting, Martin Werner, Silke Lassmann. Centrosome‐, chromosomal‐passenger‐ and cell‐cycle‐associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. The Journal of Pathology 2006; 208(4): 462 doi: 10.1002/path.1914
|
3 |
Maggie K.-L. Fung, Hiu-Wing Cheung, Hing-Lok Wong, Hiu-Fung Yuen, Ming-Tat Ling, Kowk-Wah Chan, Yong-Chuan Wong, Annie L.-M. Cheung, Xianghong Wang. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2007; 1773(6): 821 doi: 10.1016/j.bbamcr.2007.03.014
|
4 |
Natalie L. Curtis, Victor M. Bolanos-Garcia. Macromolecular Protein Complexes II: Structure and Function. Subcellular Biochemistry 2019; 93: 539 doi: 10.1007/978-3-030-28151-9_18
|
5 |
YUSUKE NAKANO, TOSHIYUKI SUMI, MASATOMO TERAMAE, MASANARI MORISHITA, TAKESHI FUKUDA, HIROYUKI TERADA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Expression of the mitotic-arrest deficiency 2 is associated with chemotherapy resistance in ovarian serous adenocarcinoma. Oncology Reports 2012; 28(4): 1200 doi: 10.3892/or.2012.1907
|
6 |
Chiara Saladino, Emer Bourke, Ciaran G. Morrison. The Centrosome. 2012; : 223 doi: 10.1007/978-1-62703-035-9_13
|
7 |
Espen Burum-Auensen, Paula M. De Angelis, Aasa R. Schjølberg, Katherine L. Kravik, Marit Aure, Ole Petter F. Clausen. Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by Immunohistochemistry. Journal of Histochemistry & Cytochemistry 2007; 55(5): 477 doi: 10.1369/jhc.6A7077.2007
|
8 |
W. Brian Dalton, Vincent W. Yang. Mitotic origins of chromosomal instability in colorectal cancer. Current Colorectal Cancer Reports 2007; 3(2): 59 doi: 10.1007/s11888-007-0001-y
|
9 |
Young Hyeh Ko, Ji Hyeon Roh, Young‐Ik Son, Man Ki Chung, Jeon Yeob Jang, Hayoung Byun, Chung‐Hwan Baek, Han‐Sin Jeong. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. Journal of Oral Pathology & Medicine 2010; 39(4): 349 doi: 10.1111/j.1600-0714.2009.00835.x
|
10 |
Andrew J Holland, Don W Cleveland. Losing balance: the origin and impact of aneuploidy in cancer. EMBO reports 2012; 13(6): 501 doi: 10.1038/embor.2012.55
|
11 |
Shanfeng Zhu, Yasushi Okuno, Gozoh Tsujimoto, Hiroshi Mamitsuka. Application of a New Probabilistic Model for Mining Implicit Associated Cancer Genes from OMIM and Medline. Cancer Informatics 2006; 2: 117693510600200 doi: 10.1177/117693510600200025
|
12 |
Sophie Gay, Daniele Piccini, Christopher Bruhn, Sara Ricciardi, Paolo Soffientini, Walter Carotenuto, Stefano Biffo, Marco Foiani. A Mad2-Mediated Translational Regulatory Mechanism Promoting S-Phase Cyclin Synthesis Controls Origin Firing and Survival to Replication Stress. Molecular Cell 2018; 70(4): 628 doi: 10.1016/j.molcel.2018.04.020
|
13 |
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives. Clinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006
|
14 |
Tara Byrne, Helen G. Coleman, Janine A. Cooper, W. Glenn McCluggage, Amanda McCann, Fiona Furlong. The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses. Oncotarget 2017; 8(60): 102223 doi: 10.18632/oncotarget.18414
|
15 |
MASANARI MORISHITA, TOSHIYUKI SUMI, YUSUKE NAKANO, MASATOMO TERAMAE, TAKESHI FUKUDA, HIROYUKI NOBEYAMA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer. Experimental and Therapeutic Medicine 2012; 3(2): 341 doi: 10.3892/etm.2011.407
|
16 |
Omar S. El-Masry, Arafat Goja, Mostafa Rateb, Amani Y Owaidah, Khaldoon Alsamman. RNA sequencing identified novel target genes forAdansonia digitatain breast and colon cancer cells. Science Progress 2021; 104(3): 003685042110320 doi: 10.1177/00368504211032084
|
17 |
YUSUKE NAKANO, TOSHIYUKI SUMI, MASANARI MORISHITA, TAKESHI FUKUDA, HIROYUKI NOBEYAMA, HIROYUKI YOSHIDA, YOSHINARI MATSUMOTO, TOMOYO YASUI, OSAMU ISHIKO. Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors. Oncology Letters 2012; 3(2): 281 doi: 10.3892/ol.2011.483
|
18 |
Miguel Abal, Antonia Obrador–Hevia, Klaus–Peter Janssen, Laura Casadome, Mireia Menendez, Sabrina Carpentier, Emmanuel Barillot, Mechthild Wagner, Wilhelm Ansorge, Gabriela Moeslein, Hafida Fsihi, Vladimir Bezrookove, Jaume Reventos, Daniel Louvard, Gabriel Capella, Sylvie Robine. APC Inactivation Associates With Abnormal Mitosis Completion and Concomitant BUB1B/MAD2L1 Up-Regulation. Gastroenterology 2007; 132(7): 2448 doi: 10.1053/j.gastro.2007.03.027
|
19 |
Norihisa Uemura, Yukihiro Nakanishi, Hoichi Kato, Masato Nagino, Setsuo Hirohashi, Tadashi Kondo. Antibody‐based proteomics for esophageal cancer: Identification of proteins in the nuclear factor‐κB pathway and mitotic checkpoint. Cancer Science 2009; 100(9): 1612 doi: 10.1111/j.1349-7006.2009.01230.x
|
20 |
Jianwei Ren, Alison Kan, Siew Hong Leong, London L.P.J. Ooi, Kuan-Teh Jeang, Samuel S. Chong, Oi Lian Kon, Caroline G.L. Lee. FAT10 Plays a Role in the Regulation of Chromosomal Stability. Journal of Biological Chemistry 2006; 281(16): 11413 doi: 10.1074/jbc.M507218200
|
21 |
Lilian Kabeche, Duane A. Compton. Checkpoint-Independent Stabilization of Kinetochore-Microtubule Attachments by Mad2 in Human Cells. Current Biology 2012; 22(7): 638 doi: 10.1016/j.cub.2012.02.030
|
22 |
Caroline Rimkus, Jan Friederichs, Robert Rosenberg, Bernhard Holzmann, Jörg‐Rüdiger Siewert, Klaus‐Peter Janssen. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. International Journal of Cancer 2007; 120(1): 207 doi: 10.1002/ijc.22155
|
23 |
Younghye Kim, Jung-Woo Choi, Ju-Han Lee, Young-Sik Kim. MAD2 and CDC20 are Upregulated in High-grade Squamous Intraepithelial Lesions and Squamous Cell Carcinomas of the Uterine Cervix. International Journal of Gynecological Pathology 2014; 33(5): 517 doi: 10.1097/PGP.0000000000000082
|
24 |
Andreas Brown, Hartmut Geiger. Chromosome integrity checkpoints in stem and progenitor cells: transitions upon differentiation, pathogenesis, and aging. Cellular and Molecular Life Sciences 2018; 75(20): 3771 doi: 10.1007/s00018-018-2891-z
|
25 |
Rocío Sotillo, Eva Hernando, Elena Díaz-Rodríguez, Julie Teruya-Feldstein, Carlos Cordón-Cardo, Scott W. Lowe, Robert Benezra. Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice. Cancer Cell 2007; 11(1): 9 doi: 10.1016/j.ccr.2006.10.019
|
26 |
Yasusei Kudo, Takaaki Tsunematsu, Takashi Takata. Deregulation of Anaphase-promoting Complex/cyclosome-dependent Proteolysis in Cancer. Journal of Oral Biosciences 2010; 52(4): 388 doi: 10.1016/S1349-0079(10)80021-0
|
27 |
D W Zhang, K-T Jeang, C G L Lee. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 2006; 25(16): 2318 doi: 10.1038/sj.onc.1209220
|
28 |
Sinjini Sarkar, Pranab Kumar Sahoo, Sutapa Mahata, Ranita Pal, Dipanwita Ghosh, Tanuma Mistry, Sushmita Ghosh, Tanmoy Bera, Vilas D. Nasare. Mitotic checkpoint defects: en route to cancer and drug resistance. Chromosome Research 2021; 29(2): 131 doi: 10.1007/s10577-020-09646-x
|
29 |
Beth AA Weaver, Don W Cleveland. Does aneuploidy cause cancer?. Current Opinion in Cell Biology 2006; 18(6): 658 doi: 10.1016/j.ceb.2006.10.002
|
30 |
Heng Wang, Wei Wang, Zhen Wang, Xu Li. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1291859
|
31 |
Mark Bates, Fiona Furlong, Michael F. Gallagher, Cathy D. Spillane, Amanda McCann, Sharon O'Toole, John J. O'Leary. Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer. Cancer Letters 2020; 469: 11 doi: 10.1016/j.canlet.2019.10.005
|
32 |
Ivar P Gladhaug, Arne Westgaard, Aasa R Schjølberg, Espen Burum‐Auensen, Ewa Pomianowska, Ole Petter F Clausen. Spindle proteins in resected pancreatic head adenocarcinomas: BubR1 is an independent prognostic factor in pancreatobiliary‐type tumours. Histopathology 2010; 56(3): 345 doi: 10.1111/j.1365-2559.2010.03489.x
|
33 |
Dang Wu, Lepeng Wang, Yanhong Yang, Jin Huang, Yuhua Hu, Yongwei Shu, Jingyu Zhang, Jing Zheng. MAD2-p31comet axis deficiency reduces cell proliferation, migration and sensitivity of microtubule-interfering agents in glioma. Biochemical and Biophysical Research Communications 2018; 498(1): 157 doi: 10.1016/j.bbrc.2018.02.011
|
34 |
Brian David Lehmann, Yan Ding, Daniel Joseph Viox, Ming Jiang, Yi Zheng, Wang Liao, Xi Chen, Wei Xiang, Yajun Yi. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1102-7
|
35 |
Tara Byrne, Laura Nelson, James P. Beirne, Daniel Sharpe, Jennifer E. Quinn, W. Glenn McCluggage, Tracy Robson, Fiona Furlong. BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma. International Journal of Gynecologic Cancer 2018; 28(3): 472 doi: 10.1097/IGC.0000000000001214
|
36 |
E. Burum‐Auensen, P. M. DeAngelis, A. R. Schjølberg, J. Røislien, O. Mjåland, O. P. F. Clausen. Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers. Cell Proliferation 2008; 41(4): 645 doi: 10.1111/j.1365-2184.2008.00539.x
|
37 |
Kirsten Hannisdal, Espen Burum‐Auensen, Aasa Schjølberg, Paula M. De Angelis, Ole Petter F. Clausen. Correlation between reduced expression of the spindle checkpoint protein BubR1 and bad prognosis in tonsillar carcinomas. Head & Neck 2010; 32(10): 1354 doi: 10.1002/hed.21342
|
38 |
Susanne M. Gollin. Mechanisms leading to chromosomal instability. Seminars in Cancer Biology 2005; 15(1): 33 doi: 10.1016/j.semcancer.2004.09.004
|
39 |
K. Tanaka, Y. Mohri, M. Ohi, T. Yokoe, Y. Koike, Y. Morimoto, C. Miki, H. Tonouchi, M. Kusunoki. Mitotic Checkpoint Genes, hsMAD2 and BubR1, in Oesophageal Squamous Cancer Cells and their Association with 5-fluorouracil and Cisplatin-based Radiochemotherapy. Clinical Oncology 2008; 20(8): 639 doi: 10.1016/j.clon.2008.06.010
|
40 |
|
41 |
Alejandro López-Saavedra, Miguel Ramírez-Otero, José Díaz-Chávez, Rodrigo Cáceres-Gutiérrez, Monserrat Justo-Garrido, Marco A. Andonegui, Julia Mendoza, Ángela Downie-Ruíz, Carlo Cortés-González, Nancy Reynoso, Clementina Castro-Hernández, Guadalupe Domínguez-Gómez, Miguel Santibáñez, Eunice Fabián-Morales, Franz Pruefer, Fernando Luna-Maldonado, Rodrigo González-Barrios, Luis A. Herrera. MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors. Cell Cycle 2016; 15(15): 2066 doi: 10.1080/15384101.2016.1198863
|